San Francisco, CANCT05572632Now EnrollingIRB Ready

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trial in San Francisco, CA

Access cutting-edge copd (chronic obstructive pulmonary disease) treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access copd (chronic obstructive pulmonary disease) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related copd (chronic obstructive pulmonary disease) treatment provided free

Apply for This San Francisco Location

Check if you qualify for this copd (chronic obstructive pulmonary disease) clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This COPD (Chronic Obstructive Pulmonary Disease) Study in San Francisco

Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation. The 10-week COPD Wellness and Plus+ Program directly addresses this gap, and yet, programs like these do not automatically lead to improved outcomes, which leads to the implementation of a Health Advocates program to address participant's social needs and barriers to healthcare.

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Provision of signed and dated informed consent form
Willingness to participate in the COPD Wellness program
40 to 90 years old
English or Spanish speaking
Physician-diagnosed COPD
Spirometry-confirmed FEV1/FVC ratio \<= 0.7 and FEV1% predicted \<80% based on GLI-O prediction equation
COPD Assessment Test ≥ 10 or history of 1+ exacerbation requiring hospitalization or 2+ outpatient exacerbations requiring steroid therapy
Currently prescribed COPD medication(s)
Ability to exercise with lower extremities
No COPD exacerbations for ≥ 6 weeks
Currently receiving care within SFHN
Note: Forced expiratory volume in the first second (FEV1); Forced vital capacity (FVC)

Exclusion Criteria

Dementia, cognitive impairment, or symptomatic psychiatric illness that would impair them from participating
Unstable cardiovascular disease (includes recent \[\<6 months\] myocardial infarction or pulmonary embolism, uncontrolled arrhythmia, poorly controlled heart failure)
Other severe co-morbidity which means exercise is contraindicated (screened by Registered Nurse in consultation with Pulmonologist)
Transmittable pulmonary infection (tuberculosis, COVID19)
Participated in pulmonary rehabilitation in the past 12-months
COPD exacerbation in the past 6 weeks
Activities restrictions that limit one's ability to engage in moderate physical activity
Other diagnosis or condition that carry a prognosis of death within the next year

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT05572632) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

COPD (Chronic Obstructive Pulmonary Disease) Treatment Options in San Francisco, CA

If you're searching for copd (chronic obstructive pulmonary disease) treatment options in San Francisco, CA, this clinical trial (NCT05572632) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd (chronic obstructive pulmonary disease) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all copd (chronic obstructive pulmonary disease) clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in San Francisco, CA

See all parkinsons disease clinical trials recruiting in San Francisco — not just this study.

Browse Parkinsons Disease Trials in San Francisco

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA